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ABSTRACT
Purpose.
To evaluate the relationship between menstrual cycle irregularity and several key
variables, and to determine whether the odds of diabetic women self-reporting menstrual cycle
irregularities is greater than non-diabetic women self-reporting menstrual cycle irregularities.
Methods.
A cross-sectional study was conducted using data from the Kentucky Women’s
Health Registry from 2006 to 2014. The data was restricted based on age (used as a proxy for
menopause status) and self-reported pregnancy and breastfeeding status, as well as eligibility to
menstruate, yielding a final population of 4,256 participants for analysis. Basic statistical
frequency analyses were conducted, stratified by menstrual cycle status. Bivariate analyses were
conducted on the data to estimate odds ratios for menstrual irregularities based on diabetes status
and adjusting for confounders. A logistic regression analysis was performed to estimate the
adjusted odds women with diabetes reporting menstrual cycle irregularities.
Results.
The unadjusted odds of self-reported menstrual cycle irregularities were
significantly greater in diabetic than non-diabetic women (OR = 2.09, p-value <0.05). This result
was no longer significant after adjusting for confounders (OR = 1.17, p-value = 0.39). When
subtypes of diabetes were considered for unadjusted analyses, type II diabetics taking insulin
only (OR = 2.74, p-value < 0.05), type II diabetics controlling by diet alone (OR = 2.52, p-value
< 0.05), and type II diabetics taking oral pills only (OR = 2.16, p-value < 0.05) yielded the
largest odds of self-reporting menstrual cycle irregularities versus non-diabetic women. In the
fully-adjusted model utilizing the diabetes subtypes variable, type II diabetes controlled by diet
only was significant (OR = 3.36, p-value = 0.02). The reduced adjusted model showed a strong,
statistically significant increase for the dichotomous diabetes variable compared to the result
from the fully-adjusted model (OR = 1.53, p-value = 0.006).
Conclusion. Results indicate a consistent relationship in self-reported menstrual cycle
irregularities among diabetic women when compared with non-diabetic women. In the expanded
diabetes variable model, type II diabetes controlled by diet only was significantly associated with
menstrual cycle irregularities, though small numbers necessitate cautious interpretation.
Multicollinearity, skewing, and bias could be impacting the results. Further analysis is needed to
determine the relationship of diabetes and menstrual cycle irregularities in adult women.
Keywords:

menstruation, diabetes, menstrual irregularities, menstrual disturbances, menses
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INTRODUCTION
Menstrual cycle irregularities, such as oligomenorrhea or amenorrhea, are an oftenoverlooked aspect of women’s health that carries a high patient burden. Menstrual cycles are
used as a general overall indicator of women’s health, and irregularities in the menstrual cycle
could be indicative of several adverse conditions, such as fertility disorders.1-3 An irregular
menstrual cycle is considered to be menstrual bleeding occurring more frequently than a 21 day
cycle, less frequently than 35-day cycles, or an irregular bleeding pattern (such as bleeding
between periods or abnormally heavy cycles).4 Currently, the most commonly prescribed
treatments for the correction of menstrual cycle dysfunctions are various forms of hormonebased contraceptives. Considering the pharmacoeconomical aspect of the patient burden
associated with adhering to a birth control regimen. For example, a 2012 study found that
women living in states mandating contraceptive coverage by private insurance companies had a
greater odds of adhering to a consistent schedule.5 For these therapies to be effective, they must
be taken consistently. However, costs associated with these therapeutics could play a significant
role in adherence. Another 2012 study examined a population of women between ages 13 and 50
who had purchased at least one oral contraceptive pill between 1996 and 2008.5 The data was
compiled from the Medical Expenditures Panel Survey.6 Users of combined-hormone oral
contraceptive pills spent an average of $16 per pack while users of progestin-only pills spent an
average of $13 per pack, yielding an average yearly expenditure of $192 and $156 respectively.6
While the study did not explicitly state an average out-of-pocket expenditure based on insurance
status, the authors noted that women with private insurance were less likely than uninsured
women to pay $15 or more per pack; Medicaid enrollees saw this likelihood decrease even
further.5 A 2015 study found that this burden was significantly eased by the Affordable Care Act,
4

increasing substantially the proportion of women with no co-pay for contraceptives7, as well as
increasing the proportion of women with insurance.
Comorbid health conditions, such as diabetes, may explain menstrual dysregulation in
some women. Diabetes is one of the most common chronic diseases in the United States, and,
indeed, within Kentucky. The CDC reports that 9.3% of the American population has diabetes8,
and an age-adjusted estimate of 11.3% of women in Kentucky had diabetes as of 2014.9 This
number is only expected to rise alongside the increasing obesity rate.
The relationship between diabetes and menstrual dysregulation in adult women is not
well understood, given the inconsistent results from prior analyses and limited literature
available on the subject. Using data from the Kentucky Women’s Health Registry (KWHR), this
study will characterize menstrual cycle dysregulation among adult women in Kentucky and
evaluate its risk factors, emphasizing its relationship to diabetes.

Literature Review
Data on menstrual cycles are generally self-reported. Regarding the validity of the selfreported data, a 2008 study found that “on average, women overestimated their cycle length by
0.7 days”.2 Moreover, data from sexually active populations within the study were more accurate
than data from unmarried women who are not sexually active.2 The authors note this difference
could be due to the need for “family planning” methods among sexually active populations.2
Menstrual cycle irregularities have been shown to be linked to many diseases, such as metabolic
disorders.1 A 2016 Iranian study found significant risk for type 2 diabetes and pre-diabetes
among women with irregular menstrual cycles when compared to women with regular menstrual
cycles: the adjusted hazard ratios were 1.73 and 1.33, respectively.1 This finding may suggest
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that diabetes and menstrual dysregulation share a common set of risk factors, or that disruptions
in reproductive hormones may affect the endocrine system, or perhaps both.
Literature on the relationship between menstrual cycles and diabetes is limited, with most
available studies focusing primarily on adolescent health and type 1 diabetes. The exact
physiological relationship between the two is also not well-defined, though it seems that it hinges
on gonadotropin-releasing hormone (GnRH) release.10 A 1994 review details several possible
pathophysiological relationships between menstruation and insulin-dependent diabetes, citing the
impact of insulin and insulin-like growth factor-1 (IGF-1) in hormone synthesis and overall
gonadal physiology.10 Ovarian function has also been shown to not be significantly affected by
diabetes in human.10 Possible disturbances in ovarian function (such as ovarian atrophy) have
been observed in diabetic animals, and progesterone production has been restored through
controlled dosing with insulin.10 The authors note, however, that “while hyperandrogenaemia
may occur in women with [insulin-dependent diabetes mellitus], it is not typically a significant
factor responsible for anovulation.”10 The authors also found conflicting evidence of GnRHstimulated luteinizing hormone release due to “different methods of patient selection in various
cited studies.”10 The primary physiological relationship of interest posited by the authors deals
with hypothalamic function, noting a possible interruption in hypothalamic function and GnRHrelease “in women with poorly controlled diabetes mellitus” while acknowledging that the exact
reason for this is unclear.10
A 1984 study sought to determine the effect of diabetes on age at menarche among a
group of 211 adolescents between 9 and 25 years of age.11 The study found that no significant
differences in menstrual cycle regularity exist between populations of non-diabetic and diabetic
adolescents, but that age at menarche did seem delayed among adolescents with a diabetic onset
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occurring during puberty rather than before.11 Like the 1994 study10, this study noted the likely
disruption to be due to the influence the condition has on the hypothalamic-pituitary-gonadal
axis maturation in females with a diabetic onset occurring during puberty, which results in a
disruption in sexual maturation.11 It is worth noting, however, that this study suffers from
significant selection bias, as the population only included white females within 20% of the ideal
body weight, and is thus not generalizable to the general population. The inclusion of children
who have not reached menarche may also create bias in this study.
By contrast, a 2008 Italian study of similar design, also conducted solely on white
females, found age at menarche to be delayed among patients with type 1 diabetes, and found no
significant association with increased HbA1c levels or BMI.12 This study could also be
influenced by significant selection bias and a lack of generalizability to the larger population.
Similarly, a cross-sectional study in 2011 using NHANES data for a population of women
between the ages of 12 and 24 found that “the age of menarche in adolescent females with
premenarchal presentation of [type 1 diabetes mellitus] continues to be delayed.”13 This study
also found that poor metabolic control (as shown by the significant negative correlation found
among women with a higher BMI than women with a lower BMI regarding age at menarche)
could play an important role in age at menarche.13
A 2015 study, however, using self-reported answers to a questionnaire for a group of
women over age 18, found no significant difference in age at menarche between women with
type 1 diabetes and the control group, while also failing to find any significant differences in
menstrual cycle irregularities between the groups (approximately 33.2% overall for type 1
diabetics of all ages compared to approximately 30.2% in the control group, with a p-value of
0.2).14
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A 1992 Danish study sought to characterize 570 women between ages 18 and 49 in a
particular county based on menstrual cycle status, with diabetic cases ascertained using
prescription records.15 The control group was recruited through a random selection process using
the registration of persons living in the county at the Odense University Hospital.15 The
researchers found a significant difference in all menstrual cycle irregularity categories analyzed
(primary amenorrhea, secondary amenorrhea, and oligomenorrhea/polymenorrhea).15 Similarly,
a 1995 study by Yeshaya and colleagues of 100 diabetic patients with a mean age of 22 years,
found 32% of this population reporting menstrual disturbances during the observation period,
though the observation period is never clearly defined within the context of the study.16 The
primary conclusion by these authors is that menstrual disturbances are more frequent in patients
with poorly controlled diabetes.16 These authors also cite possible hypothalamic-pituitaryovarian axis function being influenced by insulin, additionally noting that the impact of weight
and body fat should not be overlooked.16
A 2003 study limited to women with type 1 diabetes and comparing them to their nondiabetic sisters and unrelated control subjects also found a significant increase in menstrual cycle
irregularities among women with type 1 diabetes than the control groups.17 When analyzed by
age category in the univariate model, however, the results shift to statistically different menstrual
irregularities being found only among type 1 diabetic women under age 20 and between ages 20
and 29, with no statistically different results found in the two other age categories (30-39 years
and 40-49 years).17 These results were echoed in their final logistic regression models, though
the only results provided by the authors are odds ratios for women with type 1 diabetes, making
further interpretation of the authors’ results difficult.17 The study also collapses younger women
into one category, women less than 20 years of age.17

8

Utilizing HbA1c levels to determine adolescents’ (age 12 to 18) diabetic control, a 2010
age-matched case-control study conducted in Greece found that both the incidence and odds of
oligomenorrhea were significantly increased among women with type 1 diabetes than the
controls (28.4% among the women with type 1 diabetes, compared to the 5.5% among the
controls).18 This study showed an increased prevalence of menstrual irregularities among
adolescents with type 1 diabetes.19 A similar 2010 study conducted in Santiago, Chile found that
menstrual irregularities are common among adolescents, but “menstrual irregularities become
more severe with poor metabolic control.”20 In this prospective study, the patients, all of whom
had reached menarche and were under age 19, were asked to self-report days of menstrual cycles
using a calendar which the patients were to highlight and, as in the Greek study18, HbA1c levels
were utilized to determine the extent of diabetic control.20 However, bias cannot be excluded in
this result, as the authors note that the control group was contacted monthly by telephone to fill
out their calendars, while the group of girls with type 1 diabetes had their menstrual cycles
recorded monthly at the hospital.20
Many studies also highlighted physical symptoms occurring alongside diabetes and
irregular menstruation, particularly in regards to hyperandrogenism. The aforementioned 2015
study found no significant differences in self-reporting of hirsutism between the women with
type 1 diabetes and the control group, with 38% of women with type 1 diabetes compared to
43% of controls.14 In 2012, a cross-sectional study in France examined the relationship between
hirsutism and menstrual irregularities in girls with either obesity or type 1 diabetes.21 This study
found significantly higher results of menstrual irregularities and symptoms of hyperandrogenism
among women with elevated body mass indexes (BMIs) than among women with type 1
diabetes.21 Another 2012 study giving an overview of the reproductive characteristics of women
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with type 1 diabetes in Chile found that between “20-30% of the young adult women with [type
1 diabetes]” displayed symptoms of excess androgen, which was higher than the Chilean general
population (3%) and the Spanish general population (7.1%).22 The authors also found an
increased prevalence of polycystic ovarian syndrome (PCOS) in women in Chile and Spain with
type 1 diabetes: among the Chilean women with type 1 diabetes, the observed prevalence was
12%, while the Spanish women with type 1 diabetes had an observed prevalence of 18.8%),
compared to the prevalence in the general Spanish population, which lingers at approximately
6.5%.22 Several of these studies note the relationship between irregular menstruation, insulin
resistance, and excess androgens converging in another common endocrine disorder: PCOS.22-23
PCOS is a disease impacting a large population of women, the exact extent of which is hard to
determine due to lack of surveillance on the disease. Various estimates placed the number of
women impacted by the disease anywhere between 4% and 12%.24-26 PCOS is a disease
hallmarked, in part, by the presence of insulin resistance and the oligomenorrhea or amenorrhea,
though these characteristics are not necessary for the diagnosis of the disease.26,27 This condition
could also give significant insight into the exact mechanistic relationship between diabetes and
menstrual cycle dysfunction, though further research is needed to determine the exact extent to
which the conditions are related.
Finally, there is some indication that menstruation also affects diabetes. In a 1977 study,
using interviews by physicians on patients admitted to care for ketoacidosis from January 1974
to June 1976, the researchers sought to uncover changes in insulin dosing and dietary habits in or
around the patients’ menstrual cycles.28 The authors found a significant difference in diabetic
control, particularly in regards to hyperglycemia near or during the time of menstruation among
the women questioned by the doctors, though a significant volume of unacknowledged recall
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bias may be affecting the overall results of the study.28 A 1998 study of Pima Indian women also
found that the prevalence of type 2 diabetes was higher among women who had reported
menstrual cycle irregularities (at 33% compared to 24% in the controls).23

METHODS
A cross-sectional study design was created using data from the Kentucky Women’s
Health Registry (KWHR), obtained from years 2006 to 2014, contributing an initial population
of 52,020 de-identified observations with 16,645 unique participants. The data was limited to
years in which both pregnancy and breastfeeding data was available (2009 to 2014) and limited
to the first observation from each individual in the study based on the unique ID variable
assigned to them by KWHR. This created a population of 38,570 subjects, consisting of 13,632
unique participants. Women who were unable to menstruate due to self-reported conditions were
excluded from the analysis; these populations included women over age 45 (considered the
average age for perimenopausal women29), women who reported that they had been pregnant or
breastfeeding within the past year (including women who suffered from ectopic pregnancies),
women who had undergone a hysterectomy, and women who had both ovaries removed.
Variables were not available for other medical conditions that could result in amenorrhea. Age
was used as a proxy for menopause status, despite the availability of menopause data in KWHR,
because of the limitations of the menopause outcomes data within the survey (C. Brancato, email
correspondence, December 7, 2016). After the restriction of the data to the eligible population,
4,256 participants remained in the analysis. The University of Kentucky Institutional Review
Board (IRB) approved all research activities conducted in the original KWHR. No IRB approval
was required for this secondary analysis of de-identified data.
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Menstrual Cycles
A dichotomous variable for self-reported menstrual cycle irregularity was utilized in the
analysis, designating the participants’ responses to the survey question “During the past year,
have you experienced any of the following?” in which irregular menstrual cycles was an option
for response. The referent group for the analysis was women indicating no menstrual cycle
irregularities. Observations in which data was missing for this question was excluded from the
population. A variable was available regarding length of cycle, but was not utilized due to the
potential for misclassification bias based on the levels of the variable, which included options for
within the past 2 months, between 2 months to 1 year, between 1-3 years, between 3-5 years,
more than 5 years ago, and never had a menstrual cycle.

Diabetes
The diabetes variable included several categories of diabetes subtypes. A dichotomous
variable for diabetes status was created, but the subtype variable with multiple categories was
also utilized in the analysis because of the uniqueness in identifying not only different types of
diabetes, but also different treatments. Diabetes was measured based on self-reported data from
the survey responses, and included information on whether an observation was an insulin
resistant or glucose resistant diabetic or pre-diabetic, a type I diabetic, a type II diabetic
controlling the condition through diet only, a type II diabetic controlled by oral pills only, a type
II diabetic taking insulin, a type II diabetic using both oral pills and insulin, unknown type of
diabetes, and non-diabetic. The referent group for this population was women reporting no
diabetes.
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Confounders
Confounders considered for this analysis were age, weight, race and ethnicity, smoking
status, type of health insurance and education level (used as a proxy for socioeconomic status),
activity level, general health status, current stress level, problems controlling worry, excessive
anxiety and worry, gynecological conditions such as polycystic ovarian syndrome and
endometriosis, hormone therapy usage, and whether a subject was currently trying to lose
weight. These confounders were measured via self-reported status. With the exception of age and
weight, the variables analyzed were dichotomous. Many of the analyzed confounders were also
included in similar analyses, in particular the 1992 Danish study15 and the 1998 Pima Indian
study23. These confounders were chosen based on their relation to menstrual cycle irregularities,
and were examined within the analysis for association with diabetes.
Age, weight, race and ethnicity, smoking status, and the socioeconomic status proxy, type
of health insurance and education level, are basic demographic characteristics examined for
relation to both diabetes and menstrual cycle irregularities. An insurance variable was created
using the dichotomous variables provided in the dataset, in which the data was categorized from
federal and state issued insurance levels (Medicare or Medicaid) to private insurance. A race
variable was also created, utilizing the dichotomous race variables and the variable for primary
race in instances where more than one race was identified by the participant. A participant was
categorized in a race category if they marked only one race in the dichotomous variable level or
identified a primary race in the leveled variable. The creation of this variable resulted in 4
observations lost from the study, as not all participants identified a primary race. BMI was
utilized over the weight variable to account for theoretical adiposity and weight distribution.31
Weight was assessed as a potential effect modifier.12, 15, 30 A categorical variable for BMI was
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created based on WHO standards: a BMI over 25 was considered overweight, while a BMI under
18.5 was considered underweight.30-33
Activity level, current stress level, problems controlling worry, excessive anxiety and
worry, and whether a woman was currently trying to lose weight all are known to impact
menstrual cycle regularity. General health status, other gynecological conditions, and hormone
usage were considered because of their relationship with menstrual cycle regularity, since, as
noted earlier, menstrual cycle regularity is often used as a proxy for overall gynecological health.
Data was available for several different types of birth control currently being utilized by
the women in the survey, including tubal ligation, emergency contraceptives, Implanon, Norplant
implants, Depo Provera, Mirena/Paragard, birth control patches, and birth control pills. A new
variable was created, indicating whether the method of birth control was likely to provoke
regular menstrual cycles (birth control pills and birth control patches), unlikely to impact
menstrual cycles (tubal ligation34, emergency contraceptives35, and Norplant implants36), or
likely to eliminate menstrual cycles (Mirena/Paragard37, Implanon38, and Depo Provera39).
Information on other birth control methods, such as Nuvaring, was not available for analysis.
This multi-leveled variable was utilized for analysis over the individual dichotomous variables
for each of the birth control variable due to small numbers in each of the dichotomous variables.
Hormone usage was also combined into a dichotomous variable, due to small numbers in the
cells for the individual dichotomous variables.

Statistical Analyses
Basic statistical descriptors of the data were obtained using frequency analyses to analyze
the data based on menstrual cycle status. Analyses using the dichotomous variable for menstrual
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cycle irregularities and the dichotomous variable for diabetes were conducted to create frequency
tables to characterize the data and distinguish differences between the two variables.
Confounders were assessed using chi-square analyses for categorical variables and a Student’s ttest for continuous variables to examine the strength of the factor in relation to both diabetes and
menstrual cycle irregularities. Bivariate analyses were conducted on the data to determine the
odds of menstrual cycle irregularities based on diabetes status and the confounders. The
Breslow-Day test was utilized to examine potential effect modifiers. Logistic regression analyses
were then conducted to test the hypothesis that diabetes is associated with menstrual cycle
irregularities. Sensitivity analyses were conducted using stratified logistic regression analyses to
examine associations of interest. Statistical analyses for this study were conducted using SAS
v9.4. A significance level of 0.05 was used.

RESULTS
After exclusions, 4,256 unique participants remained in the dataset for analysis. This
overall sample had a mean age of 33.63 (SD 6.74), with 27.68% (n=1,178) reporting menstrual
cycle irregularities. Of the total sample, 5.92% (n=252) reported having been diagnosed with
diabetes. Table 1 displays demographic information. No differences were observed between with
and without menstrual cycle irregularities by age, race, or ethnicity, and the distribution of
education was similar between groups. The women in the study population were overwhelmingly
white and non-Hispanic.
Insurance status and education level were, together, utilized as a proxy for socioeconomic
status, and both were showing to be highly significantly associated with menstrual cycle
irregularities. Women reporting menstrual cycle irregularities had a larger prevalence of no
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insurance than women reporting no menstrual cycle irregularities (OR=1.56). Women reporting
menstrual cycle irregularities also had lower education in the overall sample than women
reporting no menstrual cycle irregularities. There was also a larger number of women reporting
smoking more than 100 cigarettes in their lifetime (ever smoking) among the women reporting
the presence of menstrual cycle irregularities than among women reporting no menstrual cycle
irregularities.
Table 1. Demographic characteristics of Kentucky Women’s Health Registry participants, 20092014, stratified by menstrual cycle regularity status (N = 4,256)
Characteristic

Age, mean(SD)
Education Level, n (%)
High school diploma or less
GED
Vocational or training certificate
Some college or associate’s degree
Bachelor’s degree or higher
Other
Missing
Race, n (%)
White
Black/African-American
Asian
American Indian or Alaska Native
Native Hawaiian or Pacific Islander
Other race
Missing
Ethnicity, n (%)
Hispanic
Not Hispanic
Missing
BMI, mean (SD)
Missing
BMI Category, n (%)
Underweight
Normal weight
Overweight
Missing

Menstrual Cycle
Irregularities
Present
n = 1,178

Menstrual Cycle
Irregularities
Absent
n = 3,078

Odds
Ratio

95%
Confidence
Interval

33.22 (6.79)

33.79 (6.72)

0.99

(0.98, 0.999)

51 (4.34)
16 (1.36)
45 (3.83)
345 (29.34)
690 (58.67)
29 (2.47)
2

132 (4.29)
33 (1.07)
100 (3.25)
678 (22.05)
2,048 (66.60)
84 (2.73)
3

1.15
1.44
1.34
1.51
Ref
1.03

(0.82, 1.60)
(0.79, 2.63)
(0.93, 1.92)
(1.29, 1.77)
-(0.67, 1.58)

1,118 (95.31)
34 (2.90)
8 (0.68)
5 (0.43)
2 (0.17)
6 (0.51)
5

2,879 (94.39)
122 (4.00)
26 (0.85)
8 (0.26)
4 (0.13)
11 (0.36)
28

Ref
0.72
0.79
1.61
1.288
1.41

-(0.49, 1.06)
(0.36, 1.76)
(0.53, 4.93)
(0.24, 7.04)
(0.52, 3.81)

10 (0.87)
1,145 (99.13)
23
29.09 (8.62)
37

25 (0.83)
2,972 (99.17)
81
27.50 (7.14)
101

1.04
Ref

(0.50, 2.17)
--

1.03

(1.02, 1.04)

24 (2.10)
446 (39.09)
671 (58.81)
37

49 (1.65)
1,315 (44.17)
1,613 (54.18)
101

1.44
Ref
1.23

(0.88, 2.38)
-(1.07, 1.41)
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Table 1. Continued.
Insurance, n (%)
Medicare/Medicaid
41 (3.51)
72 (2.35)
1.61
(1.09, 2.38)
VA/Tricare
22 (1.88)
36 (1.18)
1.73
(1.01, 2.96)
Private insurance
945 (80.91)
2,676 (87.45)
Ref
-Uninsured
147 (12.59)
247 (8.07)
1.69
(1.36, 2.10)
Unknown
13 (1.11)
29 (0.95)
1.27
(0.66, 2.45)
Missing
10
18
Smoking status, n (%)
Never smoker
758 (64.68)
2,115 (69.30)
Ref
-Every day smoker
144 (12.29)
266 (8.72)
1.51
(1.21, 1.88)
Some days smoker
54 (4.61)
128 (4.19)
1.17
(0.85, 1.64)
Used to smoke, but quit
216 (18.43)
543 (17.79)
1.11
(0.93, 1.33)
Missing
6
26
Key demographic figures for the Kentucky Women’s Health Registry population, stratified by menstrual cycle
regularity status, represent crude associations for age, BMI both as a continuous variable and a categorical
variable, education, insurance status, race and ethnicity, and smoking status. Of these variables, age, BMI (both
continuous and categorical), and insurance status were significant.

Of the women reporting presence of menstrual cycle irregularities, 9.25% (n=109) of
women reported diabetes, compared to 4.65% (n=143) of women reporting no menstrual cycle
irregularities (p-value <.0001, OR=2.09) (Table 2). Among the women reporting diabetes for
both groups, insulin resistant, glucose intolerant, or pre-diabetic women held the largest
percentage of observations (4.07% among women reporting menstrual cycle irregularities and
2.08% among women reporting no menstrual cycle irregularities). Type II diabetic women taking
insulin alone had the highest odds of self-reporting menstrual cycle irregularities, with these
women having odds 2.74 times higher than non-diabetic women.
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Table 2. Crude association between menstrual cycle irregularities and diabetes, Kentucky
Women’s Health Registry, 2009-2014.
Variable

Menstrual Cycle
Irregularities
Present
n = 1,178

Menstrual Cycle
Irregularities
Absent
n = 3,078

Odds
Ratio

95%
Confidence
Interval

109 (9.25)
143 (4.65)
Diabetes, n(%)
2.09
(1.62, 2.72)
Diabetes Subtypes, n (%)
Insulin resistant, glucose
48 (4.07)
64 (2.08)
2.06
(1.41, 3.02)
intolerant, or pre-diabetic
Type I diabetic
9 (0.76)
16 (0.52)
1.55
(0.68, 3.51)
Type II diabetic, diet only
11 (0.93)
12 (0.39)
2.52
(1.11, 5.72)
Type II diabetic, oral pills
26 (2.21)
33 (1.07)
2.16
(1.29, 3.64)
only
Type II diabetic, insulin only
8 (0.68)
8 (0.26)
2.74
(1.03, 7.33)
Type II diabetic, oral pills
3 (0.24)
5 (0.16)
1.65
(0.39, 6.91)
and insulin
Unknown diabetic
4 (0.34)
5 (0.16)
2.20
(0.59, 8.20)
Non-diabetic
1069 (90.75)
2935 (95.35)
Ref
-Diabetes is shown to be significantly associated with menstrual cycle irregularity status in these frequency analyses
with bivariate odds ratios.

As noted earlier, menstrual cycle irregularities are often indicative of other gynecological
issues, and, as such, may be important potential confounders.1-3 Table 3 presents self-reported
diagnoses of these conditions stratified by menstrual cycle regularity status. Many of these
variables, unsurprisingly, showed significant differences among the groups. In each case, the
conditions are reported by women with menstrual cycle irregularities by a ratio of as much as
two to three times higher than women reporting no menstrual cycle irregularities. The
constructed birth control variable showed significant differences, with the largest differences
being shown in birth control likely to provoke menstrual cycles. Curiously, hormone usage was
shown to have no significant differences among the strata, most likely due to a large percentage
of the data being missing (approximately 46% of the observations) and small numbers in each of
the cells.
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Table 3. Diagnosed gynecological conditions of Kentucky Women’s Health Registry
participants, 2009-2014, stratified by menstrual cycle regularity status (N = 4,256).
Variable

Abnormal Pap Smear, n (%)
Missing
Endometriosis, n (%)
Missing
Endometriosis Removed, n (%)
Missing
Fibroid Diagnosis, n (%)
Missing
Frequent Vaginal Infections,
n(%)
Missing
Frequent Yeast Infections, n (%)
Missing
General pelvic pain, n (%)
Infertility, n (%)
Missing
Low sex drive, n (%)
Painful or prolonged menstrual
cycles, n (%)
Pain with intercourse, n (%)
Pelvic adhesions, n (%)
Missing
PMS/PMDD, n (%)
Missing
Polycystic ovarian syndrome, n
(%)
Missing
Prolonged/heavy menses, n (%)
One ovary removed, n (%)
Missing
Severe hot flashes, n (%)
Uterine prolapse, n (%)
Missing
Uterine polyps, n (%)
Missing
Vaginal dryness, n (%)
Vulvar pain, n (%)
Other diagnosed gynecological
conditions, n (%)
Missing
Birth control level, n (%) †
No birth control
Likely to provoke menstruation
Likely to eliminate menstruation
Not likely to impact menstruation
Missing

Menstrual Cycle
Irregularities
Present
n = 1,178

Menstrual Cycle
Irregularities
Absent
n = 3,078

Odds
Ratio

95%
Confidence
Interval

370 (31.54)
5
110 (9.38)
5
34 (5.02)
501
81 (6.91)
5
49 (4.16)

855 (27.83)
6
235 (7.65)
6
82 (4.90)
1,403
164 (5.34)
6
84 (2.73)

1.20

(1.03, 1.38)

1.25

(0.99, 1.58)

1.03

(0.68, 1.55)

1.32

(0.999, 1.73)

1.55

(1.08, 2.22)

5
113 (9.63)
5
166 (14.09)
105 (8.95)
S5
529 (44.91)
709 (60.19)

6
229 (7.45)
6
223 (7.24)
141 (4.59)
6
1,133 (36.81)
1,455 (47.27)

1.32

(1.04, 1.68)

2.10
2.05

(1.70, 2.60)
(1.57, 2.66)

1.40
1.69

(1.22, 1.60)
(1.47, 1.93)

365 (22.50)
17 (1.45)
5
145 (12.36)
5
144 (12.28)

425 (13.81)
20 (0.65)
6
292 (9.51)
6
160 (5.21)

1.81
2.25

(1.53, 2.15)
(1.17, 4.30)

1.34

(1.09, 1.66)

2.55

(2.01, 3.23)

5
388 (32.94)
17 (1.45)
4
118 (10.02)
3 (0.25)
5
20 (1.71)
5
241 (20.46)
86 (7.30)
42 (3.58)

6
601 (19.53)
49 (1.60)
8
136 (4.42)
11 (0.36)
6
30 (0.98)
6
453 (14.72)
122 (3.96)
60 (1.95)

2.03
0.91

(1.74, 2.35)
(0.52, 1.58)

2.41
0.71

(1.86, 3.11)
(0.20, 2.56)

1.76

(1.00, 3.11)

1.49
1.91
1.87

(1.25, 1.77)
(1.44, 2.54)
(1.25, 2.78)

5

6

587 (53.31)
305 (27.80)
157 (14.31)
48 (4.38)
81

1,588 (53.72)
1,011 (34.20)
227 (7.68)
130 (4.40)
122

Ref
0.82
1.87
1.00

-(0.70, 0.96)
(1.50, 2.34)
(0.71, 1.41)
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Table 3. Continued.
Hormone usage, n (%)*
21 (3.27)
35 (2.14)
1.54
(0.89, 2.67)
Missing
535
1,443
How Long Between Cycles, n (%)
Within past 2 months
997 (85.00)
2821 (92.31)
Ref
-Between 2 months to 1 year
120 (10.23)
78 (2.55)
4.35
(3.24, 5.84)
Between 1-3 years
43 (3.67)
77 (2.52)
1.58
(1.08, 2.31)
Between 3-5 years ago
9 (0.77)
44 (1.44)
0.58
(0.28, 1.19)
More than 5 years ago
4 (0.34)
36 (1.18)
0.32
(0.11, 0.89)
Missing
5
22
† Leveled birth control variable was created using dichotomous variables for different methods of birth control.
Self-reported use of birth control pills or birth control patches was assigned to the “likely to provoke menstruation”
category; self-reported use of Mirena or Paragard, Implanon, or Depo Provera was assigned to the “likely to
eliminate menstruation” category; and self-reported tubal ligation and emergency contraceptive usage was
assigned to the “not likely to impact menstruation” category. No women reported use of Norplant implants, and so
the variable was not included in this leveled variable.
* Hormone usage refers to any reported use of a hormone, including hormones designed to treat infertility.

Activity level, general health status, stress level, worry level, and anxiety levels were also
stratified by menstrual cycle status (Table 4). Women reporting menstrual cycle irregularities
reported lower levels of activity, worse health, and more stress than women reporting no
menstrual cycle irregularities; these women also reported larger percentages of uncontrolled
worry or excessive anxiety, as well as larger percentages of post-traumatic stress disorder
(PTSD). Women self-reporting menstrual cycle irregularities had 3.84 times the odds of
reporting poor vs. excellent overall health status compared to women reporting no menstrual
cycle irregularities.
Table 4. Psychosocial health conditions of Kentucky Women’s Health Registry participants,
2009-2014, stratified by menstrual cycle regularity status (N = 4,256).
Variable

Level of physical activity, n (%)
Sedentary
Moderately active
Very active
Missing
General health condition, n (%)
Excellent
Very good

Menstrual Cycle
Irregularities
Present
n = 1,178

Menstrual
Cycle
Irregularities
Absent
n = 3,078

Odds
Ratios

95%
Confidence
Interval

290 (24.74)
719 (61.35)
163 (13.91)
6

607 (19.77)
1,929 (62.72)
538 (17.52)
7

1.58
1.23
Ref

(1.26, 1.97)
(1.01, 1.50)
--

149 (12.66)
453 (38.49)

551 (17.91)
1,400 (45.50)

Ref
1.20

-(0.97, 1.48)
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Table 4. Continued.
Good
401 (34.07)
880 (28.60)
1.69
(1.36, 2.09)
Fair
147 (12.49)
220 (7.15)
2.47
(1.87, 3.26)
Poor
27 (2.29)
26 (0.84)
3.84
(2.18, 6.78)
Missing
1
1
Current stress level, n (%)
Small
148 (12.57)
550 (17.91)
Ref
-Moderate
545 (46.30)
1,584 (51.58)
1.28
(1.04, 1.57)
Large
361 (30.67)
749 (24.39)
1.79
(1.44, 2.23)
Overwhelming
123 (10.45)
188 (6.12)
2.43
(1.82, 3.25)
Missing
1
7
Problems controlling worry, n (%)
Yes, in the past 12 months
416 (45.61)
849 (39.23)
1.32
(1.08, 1.62)
Yes, in my lifetime
309 (33.88)
810 (37.43)
1.03
(0.83, 1.28)
No
187 (20.50)
505 (23.34)
Ref
-Missing
266
914
Excessive anxiety or worry, n(%)
Yes, in the past 12 months
558 (47.65)
1,169 (38.12)
1.65
(1.40, 1.96)
Yes, in my lifetime
347 (29.63)
976 (31.82)
1.23
(1.03, 1.48)
No
266 (22.72)
922 (30.06)
Ref
-Missing
7
11
348 (29.82)
680 (22.27)
PTSD, n(%)
1.48
(1.27, 1.72)
Missing
11
25
790 (67.69)
1,951 (63.76)
Trying to Lose Weight, n(%)
1.19
(1.03, 1.37)
Missing
11
18
Crude associations for psychosocial health factors with menstrual cycle regularity status. Of the variables analyzed,
level of physical activity, general health condition, current stress level, excessive anxiety or worry, PTSD, and trying
to lose weight were shown to be significantly associated with menstrual cycle regularity status.

To further assess potential confounders, the population was then stratified based on selfreported diabetes status. Variables that showed significant associations with menstrual
dysregulation were analyzed for associations with diabetes (Table 5). Diabetic women in this
analysis were shown to have an average age significantly older than non-diabetic women (36.16
for diabetic women compared to 33.47 for non-diabetic women). Women with diabetes also had
a larger percentage with a BMI classifying them as overweight than non-diabetic women.
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Table 5. Demographic and psychosocial factors of the Kentucky Women’s Health Registry
participants, 2009-2014, stratified by dichotomous diabetes status (N = 4,256).
Variable

Diabetic Status
(All Types)
n = 252

Non-Diabetic
Status
n = 4013

Odds Ratio

95%
Confidence
Interval

Irregular menstrual cycles,
109 (43.25)
1,069 (26.70)
2.09
(1.62, 2.71)
n(%)
How Long Between Cycles,
n (%)
Within past 2 months
211 (84.06)
3,607 (90.67)
Ref
-Between 2 months to 1 year
22 (8.76)
176 (4.42)
2.14
(1.34, 3.40)
Between 1-3 years
11 (4.38)
109 (2.74)
1.73
(0.91, 3.26)
Between 3-5 years
5 (1.99)
48 (1.21)
1.78
(0.70, 4.5)
More than 5 years
2 (0.80)
38 (0.96)
0.90
(0.22, 3.76)
Missing
1
26
Age, mean(SD)
36.16 (6.25)
33.47 (6.47)
1.06
(1.04, 1.09)
BMI, mean(SD)
35.75 (9.31)
27.46 (7.22)
1.03
(1.02, 1.04)
BMI Category, n (%)
Underweight
1 (0.42)
72 (1.86)
0.96
(0.13, 7.22)
Normal weight
25 (10.46)
1,736 (44.75)
Ref
-Overweight
213 (89.12)
2,071 (53.39)
7.14
(4.70, 10.86)
Missing
13
125
Insurance, n (%)
Medicare/Medicaid
16 (6.35)
97 (2.44)
2.88
(1.67, 4.99)
VA/Tricare
2 (0.79)
56 (1.41)
0.62
(0.15, 2.58)
Private insurance
196 (77.78)
3,425 (86.14)
Ref
-Uninsured
37 (14.68)
357 (8.98)
1.81
(1.25, 2.62)
Unknown
1 (0.40)
41 (1.03)
0.43
(0.06, 3.12)
Missing
0
28
Education Level, n (%)
High school diploma or less
15 (5.95)
168 (4.20)
1.87
(1.07, 3.26)
GED
4 (1.59)
45 (1.13)
1.86
(0.66, 5.25)
Vocational or training
16 (6.35)
129 (3.23)
2.59
(1.50, 4.49)
certificate
Some college or associate’s
84 (33.33)
939 (23.48)
1.87
(1.40, 2.49)
degree
Bachelor’s degree or higher
125 (49.60)
2,613 (65.34)
Ref
-Other
8 (3.17)
105 (2.63)
1.59
(0.76, 3.34)
Missing
0
5
Smoking Status, n(%)
Never smoker
164 (65.08)
2,709 (68.20)
Ref
-Every day smoker
28 (11.11)
382 (9.62)
1.21
(0.80, 1.83)
Some days smoker
10 (3.97)
172 (4.33)
0.96
(0.50, 1.85)
Used to smoke, but quit
50 (19.84)
709 (17.85)
1.17
(0.84, 1.62)
Missing
0
32
Crude associations for associations for demographic and psychosocial health factors stratified by dichotomous
diabetes status. For these variables, age, BMI, and education were shown to be significantly associated with
diabetes.

Table 6 stratified diagnosed gynecological conditions by diabetes status, based on the
variables showing significant differences in menstrual cycle stratification from Table 3. From
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these analyses, abnormal pap smears, frequent vaginal infections, low sex drive, pain with
intercourse, pelvic adhesions, and uterine polyps showed no significant differences between the
women with and without diabetes. Many of the significant associations shown in this analysis
could be due, in part, to low numbers in the diabetic strata. Fascinatingly, from Table 3, women
self-reporting menstrual cycle irregularities had 2.55 times the odds of reporting a PCOS
diagnosis compared to women reporting no menstrual cycle irregularities, while diabetic women
had 9.18 times the odds of reporting a PCOS diagnosis compared to non-diabetic women.
However, many of the associations, particularly with gynecological conditions such as polycystic
ovarian syndrome, could be explained through a relationship between these conditions and
adiposity.
Table 6. Diagnosed gynecological conditions of the Kentucky Women’s Health Registry,
stratified by diabetes status. (N = 4,256)
Variable

Diabetic Status
(All Types)
n = 252

Non-Diabetic
Status
n = 4013

Odds Ratio

95%
Confidence
Interval

Abnormal pap smear, n(%)
Missing
Frequent vaginal infections,
n(%)
Missing
Frequent yeast infections,
n(%)
Missing
General pelvic pain, n(%)
Infertility, n(%)
Missing
Low sex drive, n(%)
Painful or prolonged
menstrual cycles, n(%)
Pain with intercourse, n(%)
Pelvic adhesions, n(%)
Missing
PMS/PMDD, n(%)
Missing
Polycystic ovarian
syndrome, n(%)
Missing
Prolonged/heavy menses,
n(%)
Severe hot flashes, n(%)

65 (25.79)
0
11 (4.37)

1,160 (29.05)
11
122 (3.06)

0.85

(0.64, 1.14)

1.45

(0.77, 2.72)

0
45 (17.86)

11
297 (7.44)

2.71

(1.92, 3.81)

0
43 (17.06)
34 (13.49)
0
104 (41.27)
154 (61.11)

11
346 (8.64)
212 (5.31)
11
1,558 (38.91)
2,010 (50.20)

2.18
2.78

(1.54, 3.08)
(1.89, 4.10)

1.10
1.56

(0.85, 1.43)
(1.20, 2.02)

50 (19.84)
3 (1.19)
0
44 (17.46)
0
87 (34.52)

640 (15.98)
34 (0.85)
11
393 (9.84)
11
217 (5.43)

1.30
1.41

(0.94, 1.79)
(0.43, 4.60)

1.94

(1.38, 2.73)

9.18

(6.84, 12.31)

0
97 (38.49)

11
892 (22.28)

2.18

(1.68, 2.84)

32 (12.70)

222 (5.54)

2.48

(1.67, 3.68)
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Table 6. Continued.
Uterine polyps, n(%)
4 (1.59)
46 (1.15)
Missing
0
11
Vaginal dryness, n(%)
55 (21.83)
639 (15.96)
1.47
(1.08, 2.01)
Vulvar pain, n(%)
19 (7.54)
189 (4.72)
1.65
(1.01, 2.69)
11 (4.37)
91 (2.28)
Other diagnosed
1.96
(1.03, 3.71)
gynecological conditions,
n(%)
Missing
0
11
Birth control level, n (%)†
No birth control
133 (58.59)
2,042 (53.37)
Ref
-Likely to provoke
54 (23.79)
1,262 (32.98)
0.66
(0.48, 0.91)
menstruation
Likely to eliminate
17 (7.49)
367 (9.59)
0.71
(0.42, 1.19)
menstruation
Not likely to impact
23 (10.13)
155 (4.05)
2.28
(1.42, 3.65)
menstruation
Missing
25
178
† Leveled birth control variable was created using dichotomous variables for different methods of birth control.
Self-reported use of birth control pills or birth control patches was assigned to the “likely to provoke menstruation”
category; self-reported use of Mirena or Paragard, Implanon, or Depo Provera was assigned to the “likely to
eliminate menstruation” category; and self-reported tubal ligation and emergency contraceptive usage was
assigned to the “not likely to impact menstruation” category. No women reported use of Norplant implants, and so
the variable was not included in this leveled variable.

Significant non-gynecological conditions from the analysis for the population stratified
based on diabetes status, as shown in Table 7. Diabetic women were more likely to report
themselves as being less active than non-diabetic women and in a worse general health
condition, with odds of 15.13 for self-reporting fair overall health status and 35.48 for selfreporting poor overall health status. They also reported higher levels of stress, more uncontrolled
worry, more excessive anxiety, and a larger percentage was trying to lose weight than among
non-diabetic women. The significance of these variables could be due in part, again, to the
relatively small number of diabetic women in the study population.
Table 7. Non-gynecological conditions of the Kentucky Women’s Health Registry, stratified by
diabetes status. (N = 4,256)
Variable

Level of activity, n (%)
Sedentary
Moderately active
Very active
Missing

Diabetes
(All Types)
n = 252

No Diabetes
n = 4013

Odds Ratio

95%
Confidence
Interval

94 (37.30)
137 (54.37)
21 (8.33)
0

803 (20.12)
2,508 (62.84)
680 (17.04)
13

3.79
1.77
Ref

(2.34, 6.15)
(1.11, 2.82)
--
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Table 7. Continued.
General health condition, n (%)
Excellent
10 (3.97)
690 (17.24)
Ref
-Very good
50 (19.84)
1,803 (45.05)
1.91
(0.97, 3.80)
Good
108 (42.86)
1,173 (29.31)
6.35
(3.30, 12.22)
Fair
66 (26.19)
301 (7.52)
15.13
(7.67, 29.82)
Poor
18 (7.14)
35 (0.85)
35.48
(15.25, 82.55)
Missing
0
2
Current stress level, n (%)
Small
24 (9.52)
674 (16.87)
Ref
-Moderate
112 (44.44)
2,017 (50.48)
1.56
(0.99, 2.44)
Large
75 (29.76)
1,035 (25.90)
2.04
(1.27, 3.26)
Overwhelming
41 (16.27)
270 (6.76)
4.27
(2.53, 7.20)
Missing
0
8
Problems controlling worry, n (%)
Yes, in the past 12 months
106 (50.24)
1,159 (40.45)
1.89
(1.26, 2.83)
Yes, in my lifetime
73 (34.60)
1,046 (36.51)
1.44
(0.94, 2.21)
No
32 (15.17)
660 (23.04)
Ref
-Missing
41
1,139
Excessive anxiety or worry, n (%)
Yes, in the past 12 months
134 (53.59)
1,593 (39.95)
2.14
(1.51, 3.02)
Yes, in my lifetime
72 (28.69)
1,251 (31.38)
1.46
(0.999, 2.14)
No
45 (17.93)
1,143 (28.67)
Ref
-Missing
1
17
PTSD, n(%)
72 (28.92)
956 (24.07)
1.28
(0.97, 1.70)
Missing
3
33
202 (80.48)
2,539 (63.86)
Trying to Lose Weight, n (%)
2.33
(1.70, 3.21)
Missing
1
28
Crude associations for non-gynecological factors stratified by diabetic status. Of the variables analyzed within this
table, level of activity, general health condition, current stress level, and trying to lose weight was significantly
associated with diabetes.

Based on the results from these analyses, the factors included as confounders in this
analysis were age, BMI, insurance status, education level, frequent yeast infections, general
pelvic pain, infertility, painful menstruation, PMS/PMDD, polycystic ovarian syndrome,
prolonged/heavy menses, severe hot flashes, vaginal dryness, vulvar pain, other diagnosed
gynecological conditions, birth control level, level of activity, general health condition, current
stress level, problems controlling worry, excessive anxiety or worry, and trying to lose weight.

Effect Modification
The categorical BMI and birth control level variable were tested against diabetes and
irregular menstrual cycles to measure effect modification. A Breslow-Day test was utilized to
25

test for significant differences between the odds ratios. The Breslow-Day test reported a p-value
for the analysis stratified by BMI of 0.29 and, for the analysis stratified by birth control level, a
p-value of 0.16. Based on these tests, no evidence of significant differences between odds ratios
could be justified. The variables were utilized in the logistic regression model as confounders
rather than effect modifiers. Cross-products were also run using the dichotomous diabetes
variable to test for interactions between the variable of interest and the variables in the model.
Overwhelmingly, the results of this analysis indicated no interactions, with the exception of a
couple strata of the education variable. From this, and the results of the Breslow-Day test, we
conclude there is not sufficient evidence of effect modification in the context of this analysis.

Logistic Regression Analysis
Two logistic regression models were fitted to the data, first incorporating the
dichotomous diabetes variable used throughout this analysis and then using the diabetes subtypes
variable to gain further insight into the effect of menstrual cycle irregularity on diabetes given
the confounders discovered. Table 8 shows the results of the logistic regression analysis utilizing
the dichotomous diabetes variable. Significance is indicated in this table using a bold font. In this
analysis, diabetes was not significantly associated with menstrual dysregulation. This could be
due to the number of confounders assessed in the model, as well as multicollinearity resulting
from several variables that are similar in nature. The adjusted odds ratio for diabetic women selfreporting menstrual cycle regularities was 1.17 (CI 0.82 – 1.66), indicating greater odds of
diabetic women self-reporting menstrual cycle irregularities. Very few of the assessed
confounders showed significance in this model.
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Table 8. Logistic regression analysis and adjusted odds ratios utilizing the dichotomous diabetes
variable, Kentucky Women’s Health Registry, 2009-2014.
Variable
Diabetes Status
Age, 1-year
BMI Category
Underweight
Normal Weight
Overweight
Insurance
Medicare/Medicaid
VA/Tricare
Private Insurance
Uninsured
Unknown
Education Level
High school
diploma or less
GED
Vocational or
training certificate
Some college or
associate’s degree
Bachelor’s degree
or higher
Other
Level of Activity
Sedentary
Moderately Active
Very Active
General Health
Condition
Excellent
Very Good
Good
Fair
Poor
Current Stress
Level
Small
Moderate
Large
Overwhelming
Problems
Controlling Worry
Yes, in the past 12
months
Yes, in my lifetime
No
Excessive Anxiety
or Worry
Yes, in the past 12
months
Yes, in my lifetime

Beta Estimate
0.15
-0.01

Odds Ratio
1.17
0.99

95% CI
(0.82, 1.66)
(0.97, 1.00)

Pr > ChiSq
0.39
0.04

0.16
Ref
-0.13

1.17
-0.88

(0.59, 2.32)
-(0.71, 1.08)

0.65
-0.21

0.07
0.50
Ref
0.24
-0.004

1.07
1.65
-1.28
1.00

(0.64, 1.79)
(0.85, 3.18)
-(0.95, 1.71)
(0.95, 1.71)

0.80
0.14
-0.10
0.99

0.03

1.03

(0.64, 1.66)

0.90

0.01
0.14

1.01
1.15

(0.47, 2.16)
(0.71, 1.85)

0.98
0.58

0.23

1.26

(1.02, 1.55)

0.03

Ref

--

--

--

0.05

1.05

(0.60, 1.84)

0.86

0.03
-0.03
Ref

1.03
0.97
--

(0.76, 1.40)
(0.75, 1.26)
--

0.85
0.84
--

Ref
0.02
0.20
0.34
0.54

-1.02
1.22
1.40
1.71

-(0.76, 1.35)
(0.89, 1.67)
(0.94, 2.10)
(0.80, 3.68)

-0.92
0.22
0.10
0.17

Ref
0.12
0.26
0.42

-1.12
1.30
1.52

-(0.84, 1.51)
(0.95, 1.78)
(1.02, 2.26)

-0.44
0.11
0.04

-0.12

0.89

(0.67, 1.17)

0.39

-0.12
Ref

0.89
--

(0.70, 1.13)
--

0.33
--

-0.13

0.88

(0.37, 2.08)

0.77

-0.17

0.84

(0.36, 1.98)

0.70
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Table 8. Continued.
No
Ref
---0.12
1.12
(0.92, 1.37)
0.25
Trying to Lose
Weight
-0.04
0.96
(0.71, 1.29)
0.79
Frequent Yeast
Infections
0.22
1.25
(0.95, 1.64)
0.12
General Pelvic
Pain
Infertility
0.61
1.83
(1.28, 2.62)
0.0008
Painful or
0.27
1.31
(1.07, 1.59)
0.008
Prolonged
Menstrual Cycles
0.04
1.04
(0.80, 1.36)
0.75
PMS/PMDD
Polycystic Ovarian
0.52
1.68
(1.21, 2.35)
0.002
Syndrome
Prolonged/Heavy
0.36
1.43
(1.16, 1.76)
0.0006
Menses
Severe Hot Flashes
0.58
1.78
(1.28, 2.48)
0.0006
Vaginal Dryness
0.26
1.30
(1.04, 1.62)
0.02
0.31
1.36
(0.95, 1.94)
0.09
Vulvar Pain
0.31
1.37
(0.81,
2.30)
0.24
Other
Gynecological
Conditions
Birth Control
Level
No birth control
Ref
---Likely to provoke
-0.06
0.94
(0.77, 1.16)
0.56
menstruation
Likely to eliminate
0.74
2.10
(1.58, 2.79)
<.0001
menstruation
Not likely to impact
-0.13
0.88
(0.58, 1.34)
0.55
menstruation
In this fully-adjusted logistic regression analysis model, diabetes failed to achieve statistical significance. Infertility,
painful or prolonged menstrual cycles, PCOS, prolonged or heavy menses, severe hot flashes, and vaginal dryness
managed to achieve statistical significance.

This analysis was then repeated utilizing the diabetes subtypes variable. The results of
this analysis are shown in Table 9. Significance from this analysis are again indicated by bolded
font. Type II diabetes controlled by diet alone was statistically significant in this model, with an
odds ratio of 3.36 compared to non-diabetic women (p-value of 0.02). Overwhelming stress was
shown to be statistically significant, increasing the odds of a woman reporting menstrual cycle
irregularities 54% against a woman reporting a small level of stress. Infertility was also shown to
be significant in this model, producing an odds ratio of 1.85. Finally, various variables indicating
difficult menstrual cycles (heavy menstrual cycles and painful menstrual cycles) were shown to
28

be significant in the model. Collinearity could exist between these two variables, as both
variables included the word “prolonged” in the survey question, though two very different
symptoms were being targeted by the variables -- heavy menstrual cycles aims to account for a
high volume of blood lost during a menstrual cycle while painful menstrual cycles aims to
examine the level of pain incurred during a menstrual cycle.
Table 9. Logistic regression analysis and adjusted odds ratios utilizing the expanded diabetes
variable.
Variable
Diabetes Diagnosis
Insulin resistant,
glucose intolerant,
or pre-diabetic
Type I Diabetic
Type II Diabetic,
Diet Only
Type II Diabetic,
Oral Pills Only
Type II Diabetic,
Insulin Only
Type II Diabetic,
Oral Pills and
Insulin
Unknown Diabetic
Non-Diabetic
Age, 1-year
BMI Category
Underweight
Normal Weight
Overweight
Insurance
Medicare/Medicaid
VA/Tricare
Private Insurance
Uninsured
Unknown
Education Level
High school
diploma or less
GED
Vocational or
training certificate
Some college or
associate’s degree
Bachelor’s degree
or higher
Other

Beta Estimate

Odds Ratio
1.10

95% CI
-(0.67, 1.81)

Pr > ChiSq
-0.71

0.09

-0.28
1.21

0.75
3.36

(0.26, 2.22)
(1.19, 9.47)

0.61
0.02

-0.04

0.96

(0.45, 2.09)

0.93

0.67

1.96

(0.58, 6.59)

0.28

-0.26

0.77

(0.17, 3.55)

0.74

-0.14
Ref
-0.02

0.87
-0.98

(0.18, 4.10)
-(0.97, 0.99)

0.86
-0.03

0.16
Ref
-0.14

1.17
-0.87

(0.59, 2.33)
-(0.70, 1.07)

0.65
-0.18

0.05
0.50
Ref
0.25
0.002

1.05
1.65
-1.28
1.00

(0.62, 1.76)
(0.85, 3.17)
-(0.95, 1.72)
(0.38, 2.63)

0.86
0.14
-0.10
1.00

0.02

1.02

(0.63, 1.65)

0.93

0.02
0.15

1.02
1.16

(0.48, 2.20)
(0.71, 1.88)

0.95
0.56

0.24

1.27

(1.03, 1.56)

0.03

Ref

--

--

--

0.07

1.07

(0.61, 1.87)

0.82
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Table 9. Continued.
Level of Activity
Sedentary
Moderately Active
Very Active
General Health
Condition
Excellent
Very Good
Good
Fair
Poor
Current Stress
Level
Small
Moderate
Large
Overwhelming
Problems
Controlling Worry
Yes, in the past 12
months
Yes, in my lifetime
No
Excessive Anxiety
or Worry
Yes, in the past 12
months
Yes, in my lifetime
No
Trying to Lose
Weight
Frequent Yeast
Infections
General Pelvic
Pain
Infertility
Painful or
Prolonged
Menstrual Cycles
PMS/PMDD
Polycystic Ovarian
Syndrome
Prolonged/Heavy
Menses
Severe Hot Flashes
Vaginal Dryness
Vulvar Pain
Other
Gynecological
Conditions

0.03
-0.03
Ref

1.04
0.97
--

(0.76, 1.41)
(0.75, 1.25)
--

0.82
0.82
--

Ref
0.02
0.20
0.35
0.46

-1.02
1.22
1.42
1.59

-(0.76, 1.35)
(0.89, 1.68)
(0.95, 2.13)
(0.73, 3.45)

-0.91
0.21
0.09
0.24

Ref
0.12
0.27
0.27

-1.13
1.30
1.54

-(0.84, 1.52)
(0.95, 1.79)
(1.03, 2.28)

-0.43
0.10
0.03

-0.12

0.88

(0.67, 1.17)

0.38

-0.13
Ref

0.88
--

(0.69, 1.12)
--

0.31
--

-0.16

0.85

(0.36, 2.02)

0.72

-0.20
Ref
0.11

0.82
-1.12

(0.35, 1.93)
-(0.91, 1.37)

0.65
-0.28

-0.04

0.96

(0.71, 1.29)

0.78

0.22

1.24

(0.94, 1.64)

0.12

0.61
0.27

1.85
1.31

(1.30, 2.64)
(1.08, 1.60)

0.0007
0.006

0.05
0.53

1.05
1.70

(0.81, 1.36)
(1.21, 2.39)

0.74
0.002

0.36

1.44

(1.17, 1.76)

0.0006

0.57
0.26
0.31
0.33

1.77
1.30
1.36
1.39

(1.27, 2.46)
(1.04, 1.62)
(0.96, 1.95)
(0.83, 2.34)

0.0007
0.02
0.09
0.21
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Table 9. Continued.
Birth Control
Level
No birth control
Ref
---Likely to provoke
-0.06
0.94
(0.76, 1.15)
0.54
menstruation
Likely to eliminate
0.74
2.10
(1.58, 2.80)
<.0001
menstruation
Not likely to impact
-0.11
0.90
(0.59, 1.36)
0.61
menstruation
In this fully-adjusted logistic regression analysis using the expanded diabetes variable, age, infertility, prolonged or
painful menstrual cycles, PCOS, prolonged or heavy menses, severe hot flashes, and vaginal dryness managed to
achieve statistical significance. In the expanded diabetes variable, only type II diabetics controlled by diet alone
managed to achieve significance..

Given the number of independent variables analyzed, these models could suffer from
over-adjustment. Table 10 presents a reduced model utilizing key potential confounders (based
on the literature) in the analysis, which include age, BMI, level of activity, current stress level,
PCOS, and birth control level. Age has a significant effect on the prevalence of type II diabetes,
which composes a majority of diabetes cases.40-42 Age is also known to have a regulatory impact
on menstrual cycles. BMI is well known to be associated with diabetes41,43, and BMI was also
been shown to be associated with irregular menstruation in adolescent girls in a 2014 Pakistani
study.44 Increased physical activity has been shown to have some connection to menstrual cycle
regulation and frequency, though the physiological function creating such a phenomenon is not
well understood.45 Physical activity has also been shown to be highly associated with
diabetes.41,43 The influence of mental stress on menstruation is well-known, often leading to
missed cycles. In diabetes, a 2017 study showed that mental stress is highly associated with
unhealthy eating patterns in young adults, which, in turn, influence the prevalence of diabetes.46
The relationship between diabetes and PCOS, as well as between menstrual cycle irregularities
and PCOS, was discussed in the literature review. Birth control, in all its various forms, is
pharmacological agent utilized not only to regulate conception, but also to control, provoke, or
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eliminate menstrual cycles. Birth control is also known to fluctuate blood glucose levels and
“exacerbate DM.”47
The dichotomous diabetes variable was utilized over the expanded diabetes variable
because of low numbers of observations in cell counts in the expanded diabetes variable. In this
model, almost all included variables had at least one stratum gain statistical significance. Of
primary interest, the dichotomous diabetes variable was significant, indicating diabetic woman
had 1.53 times the odds of self-reporting menstrual cycle irregularities versus non-diabetic
women. Being sedentary was statistically significant, and increased odds of self-reporting
menstrual cycle regularities compared to very active women, seemingly contradicting the lack of
statistical significance for overweight women. This could suggest multicollinearity between the
variables.
Table 10. Reduced logistic regression analysis, utilizing the dichotomous diabetes variable and
key confounders.
Variable
Diabetes Status
Age
BMI Category
Underweight
Normal Weight
Overweight
Level of Activity
Sedentary
Moderately Active
Very Active
Current Stress
Level
Small
Moderate
Large
Overwhelming
Polycystic Ovarian
Syndrome

Beta Estimate
0.42
-0.02

Odds Ratio
1.53
0.98

95% CI
(1.12, 2.07)
(0.97, 0.99)

Pr > ChiSq
0.006
0.003

0.31
Ref
0.04

1.37
-1.04

(0.81, 2.31)
-(0.89, 1.21)

0.24
-0.65

0.27
0.11
Ref

1.31
1.11
--

(1.02, 1.67)
(0.90, 1.37)
--

0.03
0.32
--

Ref
0.21
0.51
0.74
0.77

-1.24
1.66
2.10
2.16

-(1.00, 1.54)
(1.32, 2.11)
(1.54, 2.88)
(1.65, 2.83)

-0.05
<.0001
<.0001
<.0001
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Table 10. Continued.
Birth Control
Level
No birth control
Ref
---Likely to provoke
-0.22
0.80
(0.70, 0.95)
0.01
menstruation
Likely to eliminate
0.64
1.89
(1.50, 2.38)
<.0001
menstruation
Not likely to impact
-0.07
0.93
(0.64, 1.35)
0.71
menstruation
In this reduced-adjusted logistic regression analysis, diabetes, age, stress level, PCOS, and birth control level were
shown to be statistically significant..

Sensitivity Analyses
PCOS was shown to be very strongly significant in each of the logistic regression
models. PCOS was not considered as an effect modifier within the context of this analysis due to
unresolved questions regarding the direction of flow of the causal pathway between menstrual
cycle regularities and the disease, as well as diabetes and the disease. The strength of the
association, however, could indicate some influence in the causal pathway between diabetes and
menstrual cycle irregularities. A reduced logistic regression analysis stratified by PCOS status
can be found in the Appendix in Table 11 and Table 12. There is no literature to defend such a
stratification, but the strength of the association from Table 8, Table 9, and Table 10, along with
the physiology and hallmarks of the disease, created an interesting question that could contribute
to discussions surrounding PCOS.
Table 11 presents the reduced adjusted logistic regression analysis for women reporting
no PCOS diagnosis (n = 3,941). In this model, diabetes remained significant, decreasing slightly
compared to the result from Table 10 to an odds ratio of 1.49 (compared to Table 10’s 1.53).
Stress is highly significant in the model, within even a slight increase in stress to moderate
increasing the odds of a woman self-reporting menstrual cycle irregularities by 31% when
compared to a woman with a small level of stress.
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The reduced adjusted logistic regression analysis for women reporting a PCOS diagnosis
(n=304) can be found in Table 12. In this model, all variables in the reduced analysis lose
statistical significance, with the exception of age. Odds of self-reporting menstrual cycle
irregularities among diabetic women increase to 1.76 times that of non-diabetic women,
compared to the 1.49 odds found in Table 11 in the same comparison group. The effect of age on
self-reporting menstrual cycle irregularities is slightly more protective than in Table 12.
Curiously, stress, which was highly significant in the population reporting no menstrual cycle
irregularities, is highly insignificant in this population, with overwhelming stress showing a
protective effect. This could primarily be due to a small number of observations in this particular
cell (n = 35, composing 11.51% of the population of women reporting a PCOS diagnosis). Also
of interest is that birth control, regardless of categorization, is shown to be protective across all
strata.
The results of this analysis indicate a fascinating relationship between the variables and
PCOS status, indicating an interesting direction for future research. Adding the gynecological
conditions found in the fully adjusted models in Table 8 and Table 9 could yield a significantly
different result. It is also important to consider that many of the results in Table 12 could be due
to small numbers in cell counts in the data, especially when considering that the sample
population measured for this analysis consisted of only 304 subjects.

DISCUSSION
Overall, the results of this analysis yielded conflicting and inconclusive results in this
evaluation of the relationship between diabetes and menstrual cycle regularity status. The logistic
regression analyses in Table 8 and Table 9, accounting for all identified potential confounders,

34

did not show a significant association between diabetes and menstrual dysregulation. Many of
the gynecological conditions are highly correlated, and reporting one condition could lead to
reporting others; for instance, a woman reporting general pelvic pain could also be reporting
other gynecological conditions, which could result in biased estimates from the model. The
reduced logistic regression analysis in Table 10, however, showed diabetes being statistically
significant. The bivariate odds ratios in Table 1 and Table 5 also showed a strong relationship
between diabetic status and menstrual cycle irregularities. The findings in Table 1, Table 5, and
Table 10 are all consistent with findings in the 1992 Danish study15, a 2003 study17, and a 2010
Greek study.18
The expanded diabetes variable in the fully-adjusted logistic regression analysis in Table
9, however, showed one subtype of diabetes (Type II diabetes controlled through diet only) as
significantly associated with menstrual dysregulation. This result is possibly consistent with the
findings from the 1995 Yeshaya and colleagues study16 and a 2010 Chilean study20 that found
that menstrual disturbances were found only among women with poorly controlled diabetes.
These women are only treating their diabetes through lifestyle choices, which may suggest
poorer control of the disease in these women than among women who do utilize pharmacological
treatment. On the other hand, it may indicate less severe diabetes. However, it is important to
remember that there are a very small number of observations analyzed in this particular cell; the
statistical power may not be adequate to make such a determination.
Age was found to be protective against irregular menstrual cycles in Table 8, Table 9,
and Table 10, which is consistent with common knowledge regarding the regulatory impact of
age on menstrual cycles. Birth control likely to eliminate menstrual cycles was also significant in
all three models, with an odds ratio of 2.10 in Table 8 and Table 9 for a woman taking a birth
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control method likely to eliminate menstrual cycles compared to a woman not taking birth
control. In Table 10, these odds decreased to 89% greater among women taking a birth control
method likely to eliminate menstrual cycle compared to women not taking birth control. Table
10 also indicated a significant decrease in odds of self-reporting irregular menstrual cycles
among women taking a birth control method likely to provoke menstrual cycles compared to
women taking no birth control.
Being overweight was shown to be protective in all three models, though failed to
achieve statistical significance in any of the models. There are many possible explanations for
this particular result. It is important to remember that, inherently, BMI does not account for
muscle mass, and so women with a high volume of muscle mass could be incorrectly
categorized. Birth control could also be another explanation. A chi-square analysis of the
categorical BMI variable and the birth control level variable showed high correlation (p-value
<.0001). 55.72% of overweight women reported using no birth control, compared to 49.72% of
women with a normal BMI and 54.41% of women categorized as underweight. A larger
percentage of overweight women were utilizing a birth control method not likely to impact
menstruation than normal weight or underweight women (5.30% for overweight women,
compared to 2.33% for normal weight women and 1.47% for underweight women). Overweight
women were also more likely to use a method of birth control likely to eliminate menstrual
cycles than underweight or normal weight women (prevalence ratios of 1.42 and 1.12,
respectively). Another explanation could be strong associations with comorbid gynecological
conditions of BMI. For example, 12.59% of overweight women also reported a PMS or PMDD
diagnosis compared to 8.33% of underweight women and 7.57% of normal weight women (pvalue <.0001). Similarly, 10.40% of overweight women also reported a PCOS diagnosis while
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3.08% of normal weight women and 2.78% of underweight women reported the condition (pvalue <.0001).
Finally, the significance of variables such as age, severe hot flashes, and vaginal dryness
in the fully-adjusted models in Table 8 and Table 9 could indicate poor control for menopause in
the models. The average age for perimenopause (45)29 was utilized as the control for menopause
after indication that menopause outcomes in the dataset were rather unstable. Though the control
for menopause may have been appropriate, these symptoms may indicate that the method for
control was not adequate. A different control methodology for menopause could yield
significantly different results. A fully-adjusted logistic regression analysis with women reporting
severe hot flashes, most commonly associated with menopause, eliminated from the sample
population can be found in the Appendix in Table 13. There are other conditions that can cause
severe hot flashes, such as thyroid disorders, but this provided another proxy for control of
menopause in the sample.
After further restricting the population to eliminate women reporting severe hot flashes as
another proxy for menopause status, the sample contained 4,002 observations. Within this
population, 1,060 women reported menstrual cycle irregularities (p-value <.0001) and 220
women reported diabetes (p-value <.0001). The average age of this sample, overall, was 33.50
(SD 6.71) and the average BMI was 27.81 (SD 7.56). Curiously, the population in this analysis is
even more well-educated than the study population, as designed in the methods, with the largest
percentage of women in this population reporting post-graduate training (36.43%), and the
second largest percentage indicating possession of a bachelor’s degree (29.47%).
In this model, the removal of women indicating severe hot flashes created a rather
dramatic alteration in the odds found in Table 8 and Table 9, with the odds a diabetic woman in
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this study population having 1.51 times the odds of self-reporting menstrual cycle irregularities
compared to a non-diabetic woman. This analysis, when compared to the results of Table 8 and
Table 9, indicates that control for menopause in the study population may not have been
adequate to account for the population of pre-menopausal or menopausal women in this
population. Further analysis and examination is needed to control and modify such a population.
The primary strength of this analysis were the unique variables within the dataset. A
variable categorizing diabetic status into many levels provided unique insight into diabetes
within this analysis. The variable allowed examination of several different types and treatments
of diabetes, though low cell counts in many of the strata limited analyses. This variable created a
unique opportunity to evaluate a population beyond dichotomous variables and gain insight into
associations and possible mechanistic relationships. The population studied in this analysis was
also large, providing increased statistical power to these analyses and providing insight into an
understudied population regarding this question. This study also included an in-depth
characterization of women’s health issues among this population of women. A careful analysis of
potential confounders for this question within this population also provided more strength to this
population.
The dataset does suffer from a significant amount of selection bias based on the
population chosen for analysis from KWHR and selection bias. Furthermore, the population
within this analysis is more white and more educated than the general population, and, thus, is
not generalizable to a more general population. Limited information on variables and
observations could be leading to misinterpretation of results and observations. Irregular
menstruation, for instance, is defined by several different dysfunctions in menstrual cycles.4 The
codebook does not define how such a variable was defined to the survey takers, or if the survey
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takers assigned their own definition to the variable when self-reporting such status. The length of
cycle variable also presents an interesting conundrum when considering menstrual cycle
regularity status, as the lowest grouping of time for the variable is 2 months or less, which could
result in women with irregular menstrual cycles being categorized in the referent group. The
observations and classification was also dependent upon accurate self-reporting. Women who are
not aware they possess certain conditions may be causing unknown misclassification bias in this
population. Other measures, such as BMI, rely entirely on self-reported data, and so the data may
not reflect the reality for many women in this population. Furthermore, cross-sectional studies
cannot determine causation, and thus can only speak of associations rather than provide insight
into mechanistic relationships regarding menstrual cycle status and diabetes.

CONCLUSION
A strong association was consistently shown between diabetes and menstrual cycle
irregularities in all the analyses, despite several analyses lacking statistical significance.
Identifying multicollinearity, adjusting the model, and better identifying and analyzing potential
indicators of menopause status could yield significantly different results in the analysis. In the
expanded diabetes variable, type II diabetics controlling through diet alone were shown to be
significant, even in the fully-adjusted model, indicating an interesting relationship that could be
explored in further study. Small numbers within this category, however, could have a significant
effect on the strength, requiring this result to considered with caution.
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APPENDIX
Logistic Regression Analyses Stratified by PCOS Status

Table 11. Reduced adjusted logistic regression analysis and adjusted odds ratios, utilizing the
dichotomous diabetes variable and stratified for women reporting no PCOS diagnosis.
Variable
Beta Estimate
Odds Ratio
95% CI
Pr > ChiSq
Diabetes Status
0.40
1.49
(1.04, 2.14)
0.03
Age
-0.01
0.99
(0.97, 1.00)
0.01
BMI Category
Underweight
0.41
1.51
(0.89, 2.56)
0.13
Normal Weight
Ref
---Overweight
0.04
1.04
(0.88, 1.22)
0.65
Level of Activity
Sedentary
0.28
1.32
(1.02, 1.70)
0.04
Moderately Active
0.10
1.11
(0.89, 1.37)
0.35
Very Active
Ref
---Current Stress
Level
Small
Ref
---Moderate
0.27
1.31
(1.04, 1.65)
0.02
Large
0.55
1.73
(1.35, 2.21)
<.0001
Overwhelming
0.86
2.36
(1.70, 3.29)
<.0001
Birth Control
Level
No birth control
Ref
---Likely to provoke
-0.22
0.80
(0.67, 0.96)
0.02
menstruation
Likely to eliminate
0.70
2.02
(1.59, 2.56)
<.0001
menstruation
Not likely to impact
0.07
1.07
(0.73, 1.57)
0.73
menstruation
In this reduced logistic regression analysis stratified by no PCOS status, diabetes, age, activity level, stress level,
and birth control level were all shown to be statistically significant.
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Table 12. Reduced adjusted logistic regression analysis and adjusted odds ratios, utilizing the
dichotomous diabetes variable and stratified for women reporting a PCOS diagnosis.
Variable
Beta Estimate
Odds Ratio
Chi-Square
Pr > ChiSq
0.57
1.76
(0.97, 3.18)
0.06
Diabetes Status
Age
-0.05
0.95
(0.91, 1.00)
0.03
BMI Category
Underweight
-14.13
<.001
(<.001, >999.999)
0.99
Normal Weight
Ref
---Overweight
-0.21
0.81
(0.42, 1.58)
0.54
Level of Activity
Sedentary
0.39
1.48
(0.56, 3.88)
0.43
Moderately Active
0.31
1.36
(0.56, 3.28)
0.50
Very Active
Ref
---Current Stress
Level
Small
Ref
---Moderate
-0.28
0.76
(0.34, 1.68)
0.50
Large
0.23
1.25
(0.54, 2.91)
0.60
Overwhelming
-0.07
0.93
(0.32, 2.77)
0.90
Birth Control
Level
No birth control
Ref
---Likely to provoke
-0.16
0.85
(0.48, 1.52)
0.59
menstruation
Likely to eliminate
-0.29
0.75
(0.29, 1.95)
0.55
menstruation
Not likely to impact
-1.24
0.29
(0.07, 1.14)
0.08
menstruation
In this analysis, age was the only variable that managed to achieve statistical significance. The association with
diabetes in this analysis was larger than the association in Table 11.

45

Logistic Regression Analysis Eliminating Severe Hot Flashes
Table 13. Reduced-adjusted logistic regression analysis for sample population excluding women
reporting severe hot flashes, utilizing the dichotomous diabetes variable.
Variable
Beta Estimate
Odds Ratio
95% CI
Pr > ChiSq
Diabetes Status
0.41
1.51
(1.09, 2.08)
0.01
Age
-0.02
0.98
(0.97, 0.99)
0.002
BMI Category
Underweight
0.27
1.31
(0.76, 2.26)
0.33
Normal Weight
Ref
---Overweight
0.05
1.05
(0.89, 1.24)
0.54
Level of Activity
Sedentary
0.26
1.30
(1.00, 1.68)
0.05
Moderately Active
0.13
1.14
(0.92, 1.42)
0.23
Very Active
Ref
---Current Stress
Level
Small
Ref
---Moderate
0.22
1.24
(0.99, 1.56)
0.06
Large
0.47
1.60
(1.25, 2.04)
0.0002
Overwhelming
0.69
2.00
(1.43, 2.78)
<.0001
Polycystic Ovarian
0.78
2.19
(1.66, 2.89)
<.0001
Syndrome
Birth Control
Level
No birth control
Ref
---Likely to provoke
-0.22
0.80
(0.67, 0.95)
0.01
menstruation
Likely to eliminate
0.67
1.95
(1.54, 2.47)
<.0001
menstruation
Not likely to impact
-0.15
0.86
(0.57, 1.29)
0.46
menstruation
In this analysis, diabetes, age, stress level, PCOS, and birth control level were shown to be significant. Diabetes
showed a strong association with menstrual cycle regularities in this adjusted analysis.
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